	债务利息支出		日
AbbVie	USD 645M	69M	2026-03
Amgen	USD 657M	4M	2026-03
Anika Therapeutics	179.39M	556.84M	2026-03
Arrowhead Research	USD 22.5M	811K	2025-12
AstraZeneca	USD 484M	181M	2025-12
BioCryst Pharmaceuticals	USD 14.14M	5.53M	2025-12
Biogen	USD 72.6M	12.6M	2025-06
Bristol-Myers Squibb	USD 411M	21M	2026-03
Enanta Pharmaceuticals	USD 1.96M	620K	2024-12
Gilead Sciences	USD 240M	15M	2026-03
GlaxoSmithKline	GBP 167M	21M	2026-03
Halozyme Therapeutics	USD 5.51M	597K	2026-03
Heron Therapeutics	USD 600K	100K	2024-12
Immunic	197K	222K	2025-12
Incyte	USD 569K	13K	2026-03
Insmed	USD 20.08M	517K	2026-03
Ionis Pharmaceuticals	USD 17M	1000K	2026-03
J&J	USD 43M	25M	2026-03
Karyopharm Therapeutics	USD 12.62M	1.24M	2025-12
Ligand Pharmaceuticals	USD 1.78M	875K	2025-12
Merck	USD 479M	67M	2026-03
Neurocrine Biosciences	USD 1.1M	0	2024-03
Novartis	USD 343M	39M	2026-03
Novavax	USD 5.82M	342K	2025-12
Pfizer	USD 671M	40M	2026-03
PTC Therapeutics	USD 2.87B	2.82B	2026-03
Roche Holding	CHF 304M	7.5M	2025-06
Sarepta Therapeutics	USD 20.84M	13.28M	2025-12
Vertex Pharmaceuticals	USD 3.3M	0	2025-12